Atrium Therapeutics, Inc.
RNA
$10.51
-$0.84-7.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 263.90M | 267.85M | -- | -- | |
| Total Receivables | -- | 15.00M | 100.00K | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 4.51M | 2.58M | 1.54M | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 6.65M | 138.00K | 1.21M | -- | |
| Total Current Assets | 275.05M | 285.57M | 2.85M | -- | |
|
|
|||||
| Total Current Assets | 275.05M | 285.57M | 2.85M | -- | |
| Net Property, Plant & Equipment | 5.36M | 6.38M | 5.51M | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 106.00K | 415.00K | -- | -- | |
| Total Assets | 280.51M | 292.36M | 8.35M | -- | |
|
|
|||||
| Total Accounts Payable | 3.51M | 807.00K | 4.40M | -- | |
| Total Accrued Expenses | 17.27M | 9.07M | 8.69M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 1.68M | 2.68M | 3.67M | -- | |
| Total Finance Division Other Current Liabilities | 9.04M | 9.34M | 25.04M | -- | |
| Total Other Current Liabilities | 9.04M | 9.34M | 25.04M | -- | |
| Total Current Liabilities | 31.51M | 21.91M | 41.80M | -- | |
|
|
|||||
| Total Current Liabilities | 31.51M | 21.91M | 41.80M | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 34.43M | 36.35M | 29.27M | -- | |
| Total Liabilities | 65.94M | 58.26M | 71.07M | -- | |
|
|
|||||
| Common Stock & APIC | 222.87M | 221.98M | -62.71M | -- | |
| Retained Earnings | -8.06M | 12.13M | -- | -- | |
| Treasury Stock & Other | -235.00K | -- | -- | -- | |
| Total Common Equity | 214.58M | 234.10M | -62.71M | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 214.58M | 234.10M | -62.71M | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 214.58M | 234.10M | -62.71M | -- | |
|
|
|||||